admin Dean Erhardt is the President and CEO of D2 Solutions, a company that has been in existence for over 30 years. His expertise in strategic marketing and management has been acquired for more than three decades. D2 Solutions that he heads is at the forefront of healthcare technology with its background entrenched in innovation and a solid focus on real-world situations.
A Proven Track Record
With 30 plus years of experience in strategic marketing and management Dean Erhardt’s background lies within the pharmaceutical and consumer goods industries. He spent his career at several well-known firms as Express Scripts, Cardinal Health, and U.S. Healthcare. Erhardt currently holds the position of both President and CEO at D2 Solutions where he handles how it interacts with biotech companies, medical device manufacturers, eHealth providers, and pharmaceutical firms.
Moreover, he works together with channel partners like retail outlets, specialty pharmacies, Integrated Delivery Networks (IDNs), payers, long-term care facilities, hospitals, Pharmacy Benefit Managers (PBMs) as well as Dispensing Channel Pharmacies including Pharmacies Filling Mail Order Prescriptions & Pharmacies Providing Specialty Medications to Patients. Nonetheless projects international experience includes Singapore South Korea Algeria South Africa Albania.
Career Milestones
“Our solutions are non-disruptive to our existing client’s workflow. It enables them to address budgetary constraints, labor shortages, and other issues to drive better outcomes.”
– Dean Erhardt
Erhardt was Vice President of Sales and Marketing at Express Scripts prior to joining D2 Solutions, with a focus on Specialty Pharmacy Benefits Management. For the specialty and biotech therapeutic categories, he developed formularies, reimbursement models, and support programs. He had previously been the Sales and Marketing Director at Express Scripts Specialty Distribution Services where he collaborated with more than 30 pharmaceutical manufacturers on their limited distribution programmes including patient assistance programs as well as other product specific support initiatives.
Erhardt holds an MBA from the Keller Graduate School of Management as well as a Bachelor of Business Administration in Marketing from the University of Oklahoma. His board affiliations include VirMedica, Inc. and StagesSTL that reflect his commitment to professional and community engagement.
Driving Innovation at D2 Solutions
D2 Solutions since its inception in 2008 has sought to enable healthcare executives anticipate and adjust to impending needs. The company is focused on delivering solutions that address real-world problems being experienced by manufacturers, pharmacies, payers, PBMs and hospital systems.
Erhardt emphasizes the importance of innovation: “Today we don’t think about the Sony Walkman as innovative, yet at the time it was revolutionary. Unfortunately, many entities with whom D2 works are still ‘using’ the Walkman — failing to keep pace in an environment of ever-accelerating change. D2 is working with entities to move them forward, driving their point of progress.”
SaaS Solutions for the Future
“The value we’re bringing to our customers is really what motivates me.”
– Dean Erhardt
D2 Solutions is noted for its healthcare technology-driven solutions. Its Software as a Service (SaaS) offerings are geared towards realizing additional revenues, improving margins through reduction of operational costs and reducing business risks. D2 has helped patients to minimize their workloads in the entire process from diagnosing patients to administering treatment.
ComplySuite™ is a web-based, automated compliance system that streamlines ongoing accreditation, maintenance of licensure, and regulatory compliance. The system ensures that the clients are constantly updated on the recent standards and legislations.
Enhancing Patient Care with UltraTouch Engage™
Realizing traditional HUB services’ limitations, UltraTouch Engage™ was designed by D2 Solutions for enhancing patient care. This innovative platform links producers with prescribers, druggists and consumers thus offering measurable outcomes together with actable data at every stage of a patient’s drug journey. This therefore results in improved product availability as well as patient adherence leading to reduced rates of un-dispensed prescriptions and better health overall.
Challenges and Responsibilities as CEO
As the CEO, Erhardt’s chief obligation is to ensure that his team has sufficient resources for solving client problems effectively. He emphasizes on the importance of listening to clients: “Listening to customers is what really propels D2’s business and technology forward.” His solutions are never disruptive at all to our existing client’s workflow but rather they help them address budgetary constraints, labor shortages and other issues which in turn lead to improved outcomes.
Looking Ahead
According to him, leadership success comes from constant self-challenge and finding new ways out. The end result desired by D2 Solutions involves asking right questions so as to understand customer needs and develop effective solutions.
He wants D2 Solutions’ vision for the future to be driving innovative consulting and technology based solutions addressing wage inflation, efficiency, margin etc. This will continue driving this growth of the company and its value within healthcare business.
Magazine 
